Dextromethorphan Hydrobromide, Guaifenesin, Pseudoephedrine Hydrochloride

FDA Drug Profile — ACTISPEC PSE

Dextromethorphan Hydrobromide, Guaifenesin, Pseudoephedrine Hydrochloride is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including ACTISPEC PSE. Available dosage form: solution.

Drug details

Generic Name
Dextromethorphan Hydrobromide, Guaifenesin, Pseudoephedrine Hydrochloride
Brand Names
ACTISPEC PSE
Application Number
M012
Sponsor
ACTIPHARMA, LLC
NDC Codes
1
Dosage Forms
SOLUTION
Routes
ORAL
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE

Indications and Usage

Uses • temporarily relieves cough due to minor throat and bronchial irritation associated with a cold or inhaled irritants • helps loosen phlegm and thin bronchial secretions to make coughs more productive • temporarily relieves nasal congestion

Warnings

Warnings Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have • heart disease • high blood pressure • thyroid disease • diabetes • difficulty in urination due to enlargement of the prostate gland • cough accompanied by excessive phlegm (mucus) • persistent or chronic cough such occurs with smoking, asthma, chronic bronchitis or emphysema. Ask a doctor or pharmacist before use if you are taking any other oral nasal decongestant or stimulant. When using this product do not use more than directed. Stop use and ask a doctor if • nervousness, dizziness or sleeplessness occur • symptoms do not improve within 7 days or are accompanied by fever • cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or a persistent headache. These could be signs of a serious condition. If pregnant or breast-feeding , ask a health professional before use.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.